3-aminobenzamide has been researched along with FMR1-Related Primary Ovarian Insufficiency in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makogon, N | 1 |
| Voznesenskaya, T | 1 |
| Bryzgina, T | 1 |
| Sukhina, V | 1 |
| Grushka, N | 1 |
| Alexeyeva, I | 1 |
1 other study available for 3-aminobenzamide and FMR1-Related Primary Ovarian Insufficiency
| Article | Year |
|---|---|
Poly(ADP-ribose) polymerase inhibitor, 3-aminobenzamide, protects against experimental immune ovarian failure in mice.
Topics: Animals; Apoptosis; Benzamides; Enzyme Inhibitors; Female; Meiosis; Mice; Mice, Inbred CBA; Necrosis | 2010 |